Cohort demographics, HIV disease and treatment specifics, and CVD
By A Mystery Man Writer
Description
The Demographic Shift in HIV: The Aging HIV Patient
Cardiovascular and mortality outcomes with GLP-1 receptor agonists
Linda-Gail BEKKER, Director, Professor
Cardiovascular disease and risk assessment in people living with
Clinical Trial Data Needs to Reflect the Demographics of HIV, Say
Mingshu HUANG, Biostatistician I, PhD
Characteristics, Prevention, and Management of Cardiovascular
Mingshu HUANG, Biostatistician I, PhD
PDF) Neutrophil to Lymphocyte Ratio and Cardiovascular Disease
Measurement and projection of the burden of disease attributable
from
per adult (price varies by group size)